SEC Form 4 · accession 0001209191-15-009482
GENOMIC HEALTH INC · GHDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Randall S Livingston
Director
Period of report
Feb 2, 2015
Accepted (ET)
Feb 4, 2015 · 4:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131324
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 2, 2015 | M | 1,000 | $10.73 | A | 7,149 | D | |
| Common StockF1,F2,F3 | Feb 2, 2015 | S | 1,000 | $31.9308 | D | 6,149 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy) | $10.73 | Feb 2, 2015 | M | 1,000 | D | May 25, 2007 | May 25, 2016 | Common Stock | 1,000 | 1,250 | D |
Explanation of responses
- F1These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 10, 2014.
- F2Represents weighted average sale price. Actual sale prices ranged from $31.67 to $32.31.
- F3Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.